Style | Citing Format |
---|---|
MLA | Karamzad N, et al.. "Hypertension Is the Primary Component of Metabolic Syndrome Associated With Pathologic Features of Kidney Cancer: Methodological Issues." World Journal of Urology, vol. 35, no. 9, 2017, pp. 1467-1468. |
APA | Karamzad N, Ayubi E, Rahmani V, Safiri S (2017). Hypertension Is the Primary Component of Metabolic Syndrome Associated With Pathologic Features of Kidney Cancer: Methodological Issues. World Journal of Urology, 35(9), 1467-1468. |
Chicago | Karamzad N, Ayubi E, Rahmani V, Safiri S. "Hypertension Is the Primary Component of Metabolic Syndrome Associated With Pathologic Features of Kidney Cancer: Methodological Issues." World Journal of Urology 35, no. 9 (2017): 1467-1468. |
Harvard | Karamzad N et al. (2017) 'Hypertension Is the Primary Component of Metabolic Syndrome Associated With Pathologic Features of Kidney Cancer: Methodological Issues', World Journal of Urology, 35(9), pp. 1467-1468. |
Vancouver | Karamzad N, Ayubi E, Rahmani V, Safiri S. Hypertension Is the Primary Component of Metabolic Syndrome Associated With Pathologic Features of Kidney Cancer: Methodological Issues. World Journal of Urology. 2017;35(9):1467-1468. |
BibTex | @article{ author = {Karamzad N and Ayubi E and Rahmani V and Safiri S}, title = {Hypertension Is the Primary Component of Metabolic Syndrome Associated With Pathologic Features of Kidney Cancer: Methodological Issues}, journal = {World Journal of Urology}, volume = {35}, number = {9}, pages = {1467-1468}, year = {2017} } |
RIS | TY - JOUR AU - Karamzad N AU - Ayubi E AU - Rahmani V AU - Safiri S TI - Hypertension Is the Primary Component of Metabolic Syndrome Associated With Pathologic Features of Kidney Cancer: Methodological Issues JO - World Journal of Urology VL - 35 IS - 9 SP - 1467 EP - 1468 PY - 2017 ER - |